The Foundation for the Accreditation of Cellular Therapy (FACT) has awarded accreditation to The Sarah Cannon Blood and Marrow Transplant (BMT) Program at Centennial Medical Center, which is a joint program between Tennessee Oncology and Centennial Medical Center.
“FACT accreditation has become the threshold for excellence in the field of blood and marrow transplantation, and we are honored to have achieved adherence to its rigorous standards in the first full year of our program’s existence,” said Dr. Ian Flinn, program medical director for the BMT program.
“Receiving FACT Accreditation is undoubtedly a testament to the caliber of physicians and staff we have on board,” said Rocky Billups, administrator for The Sarah Cannon Cancer Center at Centennial and director of oncology program development for HCA’s TriStar Division. “We are privileged to play a role in advancing care for patients with blood and marrow disorders through compassionate treatment, education and research.”
Founded by the American Society of Blood and Marrow Transplantation and the International Society for Cellular Therapy, FACT is a non-profit foundation for standard-setting, self-assessment, inspection and accreditation in all phases of hematopoietic collection, processing and transplantation.
FACT Accreditation is voluntary and involves rigorous documentation, on-site inspections and peer review to demonstrate compliance with the standards for autologous transplants, bone marrow and peripheral cell collection and cell processing.
FACT standards are developed by panels of experts and are updated regularly to keep pace with the rapidly advancing field of cellular therapy. Accreditation is for three years, during which time the program must submit an annual report as well as report any significant changes in procedures, facilities, or personnel that may affect the nature or quality of the program.
The Sarah Cannon Blood and Marrow Transplant Program is one of seven BMT programs within HCA. Bone marrow transplantation replaces stem cells destroyed during cancer treatments and restores the body’s ability to produce blood cells and regain the vital infection-fighting functions they perform. Patients can therefore receive more aggressive treatments and recover more fully and easily than would otherwise be possible.
The Sarah Cannon Cancer Centers have provided tens of thousands of patients in the Southeast with life-saving treatments since 1991. The Blood and Marrow Transplant Program builds upon other recent cancer initiatives at The Sarah Cannon Cancer Center, including the development of a gynecological oncology program. Through the partnership with Sarah Cannon Research Institute, the centers provide access to new therapies for cancer patients through clinical trials.
Centennial Medical Center, part of HCA’s TriStar Health System®, is a 665-bed tertiary facility that is accredited by the Joint Commission on Accreditation of Healthcare Organizations. Centennial Medical Center is among the 2007 Thomson Reuters 100 Top Hospitals®. For more information about Centennial Medical Center, call TriStar MedLine at 615-342-1919 or 800-242-5662.